These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28518017)

  • 1. Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin.
    Bukreyeva I; Angoulvant A; Bendib I; Gagnard JC; Bourhis JH; Dargère S; Bonhomme J; Thellier M; Gachot B; Wyplosz B
    Emerg Infect Dis; 2017 Jun; 23(6):1039-1041. PubMed ID: 28518017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis.
    Audemard A; Le Bellec ML; Carluer L; Dargère S; Verdon R; Castrale C; Lobbedez T; Hurault de Ligny B
    Transpl Infect Dis; 2012 Dec; 14(6):E147-9. PubMed ID: 23025483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and review.
    Lanternier F; Boutboul D; Menotti J; Chandesris MO; Sarfati C; Mamzer Bruneel MF; Calmus Y; Mechaï F; Viard JP; Lecuit M; Bougnoux ME; Lortholary O
    Transpl Infect Dis; 2009 Feb; 11(1):83-8. PubMed ID: 18803616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumagillin treatment of intestinal microsporidiosis.
    Molina JM; Tourneur M; Sarfati C; Chevret S; de Gouvello A; Gobert JG; Balkan S; Derouin F;
    N Engl J Med; 2002 Jun; 346(25):1963-9. PubMed ID: 12075057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin.
    Godron A; Accoceberry I; Couret A; Llanas B; Harambat J
    Transplantation; 2013 Oct; 96(8):e66-7. PubMed ID: 24132119
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant.
    Desoubeaux G; Maakaroun-Vermesse Z; Lier C; Bailly E; Morio F; Labarthe F; Bernard L; Chandenier J
    Transpl Infect Dis; 2013 Dec; 15(6):E250-9. PubMed ID: 24298986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.
    Molina JM; Goguel J; Sarfati C; Chastang C; Desportes-Livage I; Michiels JF; Maslo C; Katlama C; Cotte L; Leport C; Raffi F; Derouin F; Modaï J
    AIDS; 1997 Nov; 11(13):1603-10. PubMed ID: 9365765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA.
    Molina JM; Goguel J; Sarfati C; Michiels JF; Desportes-Livage I; Balkan S; Chastang C; Cotte L; Maslo C; Struxiano A; Derouin F; Decazes JM
    AIDS; 2000 Jul; 14(10):1341-8. PubMed ID: 10930148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients.
    Champion L; Durrbach A; Lang P; Delahousse M; Chauvet C; Sarfati C; Glotz D; Molina JM
    Am J Transplant; 2010 Aug; 10(8):1925-30. PubMed ID: 20636462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis.
    Menotti J; Cassinat B; Porcher R; Sarfati C; Derouin F; Molina JM
    J Infect Dis; 2003 May; 187(9):1469-74. PubMed ID: 12717629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsporidiosis: an emerging and opportunistic infection in humans and animals.
    Didier ES
    Acta Trop; 2005 Apr; 94(1):61-76. PubMed ID: 15777637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient.
    Kicia M; Sędzimirska M; Sak B; Kváč M; Wesołowska M; Hendrich AB; Kopacz Ż
    Int J Infect Dis; 2018 Dec; 77():26-28. PubMed ID: 30063985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study.
    Maillard A; Scemla A; Laffy B; Mahloul N; Molina JM
    J Antimicrob Chemother; 2021 Jan; 76(2):487-494. PubMed ID: 33128055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model.
    Feng X; Reddy VK; Mayanja-Kizza H; Weiss LM; Marton LJ; Tzipori S
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2417-23. PubMed ID: 19289524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumagillin for intestinal microsporidiosis.
    Carr A; Cooper DA
    N Engl J Med; 2002 Oct; 347(17):1381; author reply 1381. PubMed ID: 12397205
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic targets for the treatment of microsporidiosis in humans.
    Han B; Weiss LM
    Expert Opin Ther Targets; 2018 Nov; 22(11):903-915. PubMed ID: 30336698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual pulmonary Enterocytozoon bieneusi microsporidiosis in an AIDS patient: case report and review.
    Sodqi M; Brazille P; Gonzalez-Canali G; Cornet M; Piketty C; Weiss L
    Scand J Infect Dis; 2004; 36(3):230-1. PubMed ID: 15119373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsporidiosis: epidemiology, clinical data and therapy.
    Anane S; Attouchi H
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):450-64. PubMed ID: 20702053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical study of microsporidiosis in French kidney transplant recipients from 2005 to 2019: TRANS-SPORE registry.
    Dumond C; Aulagnon F; Etienne I; Heng AE; Bougnoux ME; Favennec L; Kamar N; Iriart X; Pereira B; Büchler M; Desoubeaux G; Kaminski H; Lussac-Sorton F; Gargala G; Anglicheau D; Poirier P; Scemla A; Garrouste C;
    Transpl Infect Dis; 2021 Oct; 23(5):e13708. PubMed ID: 34324771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies for human microsporidia infections.
    Didier ES; Maddry JA; Brindley PJ; Stovall ME; Didier PJ
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):419-34. PubMed ID: 15954858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.